![Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer]()
Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancerZhou, Shu-Feng; Ren, Tao; Shan, Jinlu; Li, Mengxia; Qing, Yi; Wang, Guangjie; Li, Qing; Liu, Guoshan; Li, Chongyi; Peng, Yu; Luo, Hao; Zhang, Shiheng; Yang, Yuxing; Cheng, Yi; Wang, Dong; Wang, Dong · Drug Design, Development and Therapy · 2015